The maker of the Friedreich’s ataxia drug Skyclarys have disputed figures cited by the HSE for the public reimbursement of the drug, as a crunch decision on the drug’s availability looms.
Make sure to get out and support the Friedreich’s ataxia community this Sunday in their completely justified fight for access to Skyclarys. They deserve to be heard, and they deserve access to treatment.